Carbonic Anhydrase IX: Role in diagnosis prognosis and cancer therapyBEVAN, Paul; BELLDEGRUN, Arie S.BJU international. Supplement (Print). 2008, Vol 101, Num 4, issn 1465-5101, 50 p.Serial Issue

The use of positron-emission tomography in the diagnosis of tumour phenotypeDIVGI, Chaitanya.BJU international. Supplement (Print). 2008, Vol 101, Num 4, pp 36-38, issn 1465-5101, 3 p.Article

Update on partial nephrectomy and novel techniquesRIGGS, Stephen B; KLATTE, Tobias; BELLDEGRUN, Arie S et al.Urologic oncology. 2007, Vol 25, Num 6, pp 520-522, issn 1078-1439, 3 p.Conference Paper

Development of small molecule carbonic anhydrase IX inhibitorsSUPURAN, Claudiu T.BJU international. Supplement (Print). 2008, Vol 101, Num 4, pp 39-40, issn 1465-5101, 2 p.Article

Long-term outcomes of the surgical management of renal cell carcinomaLAM, John S; BELLDEGRUN, Arie S; PANTUCK, Allan J et al.World journal of urology (Print). 2006, Vol 24, Num 3, pp 255-266, issn 0724-4983, 12 p.Article

Molecular mechanisms of carbonic anhydrase IX-mediated pH regulation under hypoxiaPASTOREKOVA, Silvia; RATCLIFFE, Peter J; PASTOREK, Jaromir et al.BJU international. Supplement (Print). 2008, Vol 101, Num 4, pp 8-15, issn 1465-5101, 8 p.Article

The sensitivity of testosterone immunoassays and their role in monitoring antiandrogen therapyLEPPERT, John T; LAM, John S; BUTCH, Anthony W et al.Urologic oncology. 2006, Vol 24, Num 4, pp 277-278, issn 1078-1439, 2 p.Article

Pathobiology, prognosis, and targeted therapy for renal cell carcinoma: Exploiting the hypoxia-induced pathwayPANTUCK, Allan J; GANG ZENG; BELLDEGRUN, Arie S et al.Clinical cancer research. 2003, Vol 9, Num 13, pp 4641-4652, issn 1078-0432, 12 p.Article

Vaccine and gene therapy of renal cell carcinomaGITLITZ, Barbara J; BELLDEGRUN, Arie S; FIGLIN, Robert A et al.Seminars in urologic oncology. 2001, Vol 19, Num 2, pp 141-147, issn 1081-0943Article

Evolving principles of surgical management and prognostic factors for outcome in renal cell carcinomaLAM, John S; BREDA, Alberto; BELLDEGRUN, Arie S et al.Journal of clinical oncology. 2006, Vol 24, Num 35, pp 5565-5575, issn 0732-183X, 11 p.Article

Open surgical management of renal cell carcinoma in the era of minimally invasive kidney surgeryDAVE, Dhiren S; LAM, John S; LEPPERT, John T et al.BJU international (Papier). 2005, Vol 96, Num 9, pp 1268-1274, issn 1464-4096, 7 p.Article

Surveillance for renal cell carcinoma : Why and how? When and how often? : Kidney Cancer: Opportunity for Disease Specific Targeted TherapyKLATTE, Tobias; LAM, John S; SHUCH, Brian et al.Urologic oncology. 2008, Vol 26, Num 5, pp 550-554, issn 1078-1439, 5 p.Conference Paper

Adjuvant therapy of renal cell carcinoma : patient selection and therapeutic optionsLAM, John S; LEPPERT, John T; BELLDEGRUN, Arie S et al.BJU international (Papier). 2005, Vol 96, Num 4, pp 483-488, issn 1464-4096, 6 p.Article

Novel approaches in the therapy of metastatic renal cell carcinomaLAM, John S; LEPPERT, John T; BELLDEGRUN, Arie S et al.World journal of urology (Print). 2005, Vol 23, Num 3, pp 202-212, issn 0724-4983, 11 p.Article

Secondary hormonal therapy for advanced prostate cancerLAM, John S; LEPPERT, John T; VEMULAPALLI, Sreenivas N et al.The Journal of urology. 2006, Vol 175, Num 1, pp 27-34, issn 0022-5347, 8 p.Article

Renal cell carcinoma 2005 : New frontiers in staging, prognostication and targeted molecular therapyLAM, John S; SHVARTS, Oleg; LEPPERT, John T et al.The Journal of urology. 2005, Vol 173, Num 6, pp 1853-1862, issn 0022-5347, 10 p.Article

Actinomycin D and gemcitabine synergistically sensitize androgen-independent prostate cancer cells to Apo2L/TRAIL-mediated apoptosisZISMAN, Amnon; NG, Chuen-Pei; PANTUCK, Allan J et al.Journal of immunotherapy (1997). 2001, Vol 24, Num 6, pp 459-471, issn 1524-9557Article

Prognostic factors in renal cell carcinomaSHUCH, Brian M; LAM, John S; BELLDEGRUN, Arie S et al.Seminars in oncology. 2006, Vol 33, Num 5, pp 563-575, issn 0093-7754, 13 p.Article

Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system. CommentaryLAM, John S; SHVARTS, Oleg; LEPPERT, John T et al.The Journal of urology. 2005, Vol 174, Num 2, pp 466-472, issn 0022-5347, 7 p.Article

CL1-SR39: A noninvasive molecular imaging model of prostate cancer suicide gene therapy using positron emission tomographyPANTUCK, Allan J; BERGER, Frank; ZISMAN, Amnon et al.The Journal of urology. 2002, Vol 168, Num 3, pp 1193-1198, issn 0022-5347Article

Laparoscopic radical nephrectomyZISMAN, Amnon; PANTUCK, Allan J; BELLDEGRUN, Arie S et al.Seminars in urologic oncology. 2001, Vol 19, Num 2, pp 114-122, issn 1081-0943Article

Prognostic Impact of Preoperative Neutrophil-to-Lymphocyte Ratio in Localized Nonclear Cell Renal Cell CarcinomaDE MARTINO, Michela; PANTUCK, Allan J; HOFBAUER, Sebastian et al.The Journal of urology. 2013, Vol 190, Num 6, pp 1999-2004, issn 0022-5347, 6 p.Article

Immunohistochemical expression of carbonic anhydrase IX assessed over time and during treatment in renal cell carcinomaJENSEN, Hanne Krogh; NORDSMARK, Marianne; DONSKOV, Frede et al.BJU international. Supplement (Print). 2008, Vol 101, Num 4, pp 41-44, issn 1465-5101, 4 p.Article

Expression of CXCR3 on mononuclear cells and CXCR3 ligands in patients with metastatic renal cell carcinoma in response to systemic IL-2 therapyRECKAMP, Karen L; FIGLIN, Robert A; MOLDAWER, Nancy et al.Journal of immunotherapy (1997). 2007, Vol 30, Num 4, pp 417-424, issn 1524-9557, 8 p.Article

A novel resectoscope for transurethral resection of bladder tumors and the prostate. CommentaryPANTUCK, Allan J; BANIEL, Jack; KIRKALI, Ziya et al.The Journal of urology. 2007, Vol 178, Num 6, pp 2331-2336, issn 0022-5347, 6 p.Article